173 related articles for article (PubMed ID: 32256122)
1. Evaluation of Antiretroviral Therapy Initiated Among Pregnant Women Under Option B+ by Viral Load and CD4 Count Outcomes in Selected Hospitals of West Shewa Zone, Oromia Region, Ethiopia.
Demissie DB; Bulto GA; Mekuria WT; Dufera FN; Gamshe EN
HIV AIDS (Auckl); 2020; 12():127-134. PubMed ID: 32256122
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of undetectable and suppressed viral load in HIV-infected pregnant women initiating Option B+ in Uganda: an observational study nested within a randomized controlled trial.
Gabagaya G; Rukundo G; Amone A; Wavamunno P; Namale-Matovu J; Lubega I; Nakabiito C; Namukwaya Z; Nolan M; Malamba SS; King R; Homsy J; Fowler MG; Musoke P
BMC Infect Dis; 2021 Sep; 21(1):907. PubMed ID: 34481464
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
[TBL] [Abstract][Full Text] [Related]
5. Time to viral load suppression and its associated factors in cohort of patients taking antiretroviral treatment in East Shewa zone, Oromiya, Ethiopia, 2018.
Ali JH; Yirtaw TG
BMC Infect Dis; 2019 Dec; 19(1):1084. PubMed ID: 31881859
[TBL] [Abstract][Full Text] [Related]
6. Option B plus antiretroviral therapy adherence and associated factors among HIV positive pregnant women in Southern Ethiopia.
Tesfaye DJ; Hibistu DT; Abebo TA; Asfaw FT; Lukas K; Laelago T; Turuse EA; Kebede HG; Altaye AA; Bekele FB
BMC Pregnancy Childbirth; 2019 Feb; 19(1):82. PubMed ID: 30819147
[TBL] [Abstract][Full Text] [Related]
7. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
8. Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.
Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Mthiko BC; Phulusa J; John M; Jumbe A; Hosseinipour MC
PLoS One; 2018; 13(4):e0195033. PubMed ID: 29614083
[TBL] [Abstract][Full Text] [Related]
9. Time of HIV diagnosis, CD4 count and viral load at antenatal care start and delivery in South Africa.
Onoya D; Nattey C; Jinga N; Mongwenyana C; Sherman G
PLoS One; 2020; 15(2):e0229111. PubMed ID: 32053679
[TBL] [Abstract][Full Text] [Related]
10. Predictors of unsuppressed viral load among adults on follow up of antiretroviral therapy at selected public and private health facilities of Adama town: unmached case-control study.
Jaleta F; Bekele B; Kedir S; Hassan J; Getahun A; Ligidi T; Garoma G; Itefa K; Gerenfes T; Botore A; Kenate B; Dagafa G; Muleta D
BMC Public Health; 2022 Sep; 22(1):1770. PubMed ID: 36123609
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical and Unmasking HIV Immune Reconstitution Inflammation Syndrome in Antiretroviral-Naïve Pregnant Women: A Prospective Cohort Study.
Muthuka JK; Nyamai EM; Oluoch K; Maibvise C; Nabaweesi R
Cureus; 2024 Jan; 16(1):e52989. PubMed ID: 38406047
[TBL] [Abstract][Full Text] [Related]
12. Virological profile of pregnant HIV positive women with high levels of CD4 count in low income settings: can viral load help as eligibility criteria for maternal triple ARV prophylaxis (WHO 2010 option B)?
Njom Nlend AE; Same Ekobo C; Moyo ST; Nguetcheng GC; Ngang P; Lyeb S; Meka L; Baane M
Pan Afr Med J; 2011; 10():27. PubMed ID: 22187609
[TBL] [Abstract][Full Text] [Related]
13. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
14. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
[TBL] [Abstract][Full Text] [Related]
15. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
[TBL] [Abstract][Full Text] [Related]
16. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
[TBL] [Abstract][Full Text] [Related]
17. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
[TBL] [Abstract][Full Text] [Related]
18. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.
Yihun BA; Kibret GD; Leshargie CT
PLoS One; 2019; 14(5):e0215300. PubMed ID: 31042743
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam.
Rangarajan S; Donn JC; Giang le T; Bui DD; Hung Nguyen H; Tou PB; Danh TT; Tran NB; Nguyen DA; Hoang Nguyen BT; Doan VT; Nguyen NQ; Pham VP; Dao DG; Chen M; Zeng Y; Tieu TT; Tran MH; Le TH; Hoang XC; West G
J Virus Erad; 2016 Apr; 2(2):94-101. PubMed ID: 27482442
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
